Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maxigesic 325 Acute Dental Pain Study: A Double-blind, Placebo-controlled, Randomized, Parallel Group Comparison of the Effects of Maxigesic 325 Versus Acetaminophen, Ibuprofen and Placebo in Participants With Acute Dental Pain

NCT01420653 is registered in ClinicalTrials.gov with AFT Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT01420653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01420653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maxigesic 325 Acute Dental Pain Study: A Double-blind, Placebo-controlled, Randomized, Parallel Group Comparison of the Effects of Maxigesic 325 Versus Acetaminophen, Ibuprofen and Placebo in Participants With Acute Dental Pain
Lead sponsor
AFT Pharmaceuticals, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
January 31, 2015
Enrollment
408 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dental pain